Method and Kit of Detecting the Absence of Micro-Organisms
Abstract
Methods of detecting the absence or presence of a micro-organism in a sample comprising: contacting the sample with a nucleic acid molecule which acts as a substrate for nucleic acid modifying activity of the micro-organism in the sample, incubating the thus contacted sample under conditions suitable for nucleic acid modifying activity; and specifically determining the absence or presence of a modified nucleic acid molecule resulting from the action of the nucleic acid modifying activity on the substrate nucleic acid molecule to indicate the absence or presence of the micro-organism. Corresponding kits are also provided.
Claims
exact text as granted — not AI-modified1 - 59 . (canceled)
60 . A kit comprising at least one nuclease resistant nucleic acid molecule comprising a plurality of nuclease resistant nucleotides, wherein the at least one nuclease resistant nucleic acid molecule can be extended in the presence of polymerase activity or ligated in the presence of ligase activity of a micro-organism in a sample, wherein the at least one nuclease resistant nucleic acid molecule is at least partially double stranded and comprises uracil residues in the complementary strand.
61 . The kit of claim 60 wherein the nuclease resistant nucleic acid molecule comprises synthetic nucleotides, methylated nucleotides or nucleotides protected of the 3′ and/or 5′ ends.
62 . The kit of claim 61 wherein the synthetic nucleotides comprise phosphorothioate nucleotides and/or locked nucleic acid nucleotides.
63 . The kit of claim 60 wherein the complementary strand of the nucleic acid molecule comprises a modification at the 3′ end to prevent extension.
64 . The kit of claim 63 wherein the modification at the 3′ end comprises incorporation of a non-extendible nucleotide.
65 . The kit of claim 64 wherein the non-extendible nucleotide is a dideoxy nucleotide triphosphate (ddNTP), optionally wherein the ddNTP is dideoxyCytidine.
66 . The kit of claim 60 further comprising at least one internal positive control (IPC) nucleic acid molecule which comprises identical primer binding sites to the nuclease resistant nucleic acid molecule such that there is competition for primer binding in a nucleic acid amplification reaction containing both the nucleic acid molecule and the IPC.
67 . The kit of claim 66 wherein the IPC nucleic acid molecule is modified so as to protect it from nuclease activity.
68 . The kit of claim 67 wherein the modification of the IPC nucleic acid molecule is selected from incorporation of synthetic nucleotides, incorporation of methylation and protection of the 3′ and/or 5′ ends.
69 . The kit of claim 68 wherein the synthetic nucleotides comprise phosphorothioate nucleotides and/or locked nucleic acid nucleotides.
70 . The kit of claim 60 further comprising a nucleic acid probe which binds to a target probe sequence within the at least one nuclease resistant nucleic acid molecule.
71 . The kit of claim 70 wherein the nucleic acid probe is labelled.
72 . The kit of claim 66 further comprising a further nucleic acid probe which binds to a target probe sequence within the IPC nucleic acid molecule.
73 . The kit of claim 72 wherein the further nucleic acid probe is labelled.
74 . The kit of claim 60 further comprising a high pH reagent.
75 . The kit of claim 74 wherein the high pH reagent comprises NaOH or Na 2 CO 3 .
76 . The kit of claim 74 wherein the concentration of the high pH reagent is around 5 mM or greater.
77 . The kit of claim 60 further comprising a pH lowering agent.
78 . The kit of claim 77 wherein the pH lowering reagent comprises a buffer or an acid.
79 . The kit of claim 78 wherein the buffer comprises a Tris-HCl buffer (pH 7.2 or 8).Join the waitlist — get patent alerts
Track US2024018605A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.